EcoDrugPlus

Thromboxane A2 Receptor

Ensembl ID : ENSMZEG00005020623
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thromboxane-A Synthase

Ensembl ID : ENSMZEG00005017016
Gene Symbol: LOC101479408
3 Cross references
208 Possible Orthologues:

Thromboxane-A Synthase-Like

Ensembl ID : ENSMZEG00005016997
Gene Symbol: LOC101486083
3 Cross references
209 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSMZEG00005019135
Gene Symbol: TYMP
4 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSMZEG00005001459
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMZEG00005017053
Gene Symbol: THRB
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSMZEG00005011478
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSMZEG00005026168
Gene Symbol: TRHRB
1 Cross references
193 Possible Orthologues:

Tissue Factor

Ensembl ID : ENSMZEG00005015326
Gene Symbol: LOC101471227
2 Cross references
172 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSMZEG00005011279
Gene Symbol: TLR2
1 Cross references
171 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSMZEG00005011356
Gene Symbol: TLR2
4 Cross references
170 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSMZEG00005011242
Gene Symbol: TLR2
2 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).